223 related articles for article (PubMed ID: 32071043)
1.
Rice CA; Lares-Jiménez LF; Lares-Villa F; Kyle DE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071043
[No Abstract] [Full Text] [Related]
2. Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen
Laurie MT; White CV; Retallack H; Wu W; Moser MS; Sakanari JA; Ang K; Wilson C; Arkin MR; DeRisi JL
mBio; 2018 Oct; 9(5):. PubMed ID: 30377287
[No Abstract] [Full Text] [Related]
3. The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.
Phan IQ; Rice CA; Craig J; Noorai RE; McDonald JR; Subramanian S; Tillery L; Barrett LK; Shankar V; Morris JC; Van Voorhis WC; Kyle DE; Myler PJ
Sci Rep; 2021 Nov; 11(1):21664. PubMed ID: 34737367
[TBL] [Abstract][Full Text] [Related]
4. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Kulsoom H; Baig AM; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
[TBL] [Abstract][Full Text] [Related]
5. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.
Roy SL; Atkins JT; Gennuso R; Kofos D; Sriram RR; Dorlo TP; Hayes T; Qvarnstrom Y; Kucerova Z; Guglielmo BJ; Visvesvara GS
Parasitol Res; 2015 Dec; 114(12):4431-9. PubMed ID: 26329128
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on
Rice CA; Troth EV; Russell AC; Kyle DE
Pathogens; 2020 Jun; 9(6):. PubMed ID: 32560115
[TBL] [Abstract][Full Text] [Related]
7. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
8. A case of fatal amoebic encephalitis caused by Balamuthia mandrillaris, China.
Ai J; Zhang H; Yu S; Li J; Chen S; Zhang W; Mao R
Infect Genet Evol; 2022 Jan; 97():105190. PubMed ID: 34954104
[TBL] [Abstract][Full Text] [Related]
9. The isolation of Balamuthia mandrillaris from environmental sources from Peru.
Cabello-Vílchez AM; Reyes-Batlle M; Montalbán-Sandoval E; Martín-Navarro CM; López-Arencibia A; Elias-Letts R; Guerra H; Gotuzzo E; Martínez-Carretero E; Piñero JE; Maciver SK; Valladares B; Lorenzo-Morales J
Parasitol Res; 2014 Jul; 113(7):2509-13. PubMed ID: 24781021
[TBL] [Abstract][Full Text] [Related]
10. Laboratory testing of clinically approved drugs against Balamuthia mandrillaris.
Kalsoom H; Baig AM; Khan NA; Siddiqui R
World J Microbiol Biotechnol; 2014 Sep; 30(9):2337-42. PubMed ID: 24875138
[TBL] [Abstract][Full Text] [Related]
11. Balamuthia mandrillaris Granulomatous Amoebic Encephalitis: The First African Experience.
Tootla HD; Eley BS; Enslin JMN; Frean JA; Hlela C; Kilborn TN; Moodley B; Peer S; Singh S; Nuttall JJC
J Pediatric Infect Dis Soc; 2022 Dec; 11(12):578-581. PubMed ID: 36041049
[TBL] [Abstract][Full Text] [Related]
12. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl.
Wu X; Yan G; Han S; Ye Y; Cheng X; Gong H; Yu H
Emerg Microbes Infect; 2020 Dec; 9(1):1379-1387. PubMed ID: 32552393
[TBL] [Abstract][Full Text] [Related]
14. Balamuthia mandrillaris in South America: an emerging potential hidden pathogen in Perú.
Cabello-Vílchez AM; Rodríguez-Zaragoza S; Piñero J; Valladares B; Lorenzo-Morales J
Exp Parasitol; 2014 Nov; 145 Suppl():S10-9. PubMed ID: 24858923
[TBL] [Abstract][Full Text] [Related]
15. The in vitro efficacy of antimicrobial agents against the pathogenic free-living amoeba Balamuthia mandrillaris.
Ahmad AF; Heaselgrave W; Andrew PW; Kilvington S
J Eukaryot Microbiol; 2013; 60(5):539-43. PubMed ID: 23869955
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Balamuthia mandrillaris from soil samples in North-Western Iran.
Niyyati M; Karamati SA; Lorenzo Morales J; Lasjerdi Z
Parasitol Res; 2016 Feb; 115(2):541-5. PubMed ID: 26468147
[TBL] [Abstract][Full Text] [Related]
17. An autopsy case of Balamuthia mandrillaris amoebic encephalitis, a rare emerging infectious disease, with a brief review of the cases reported in Japan.
Itoh K; Yagita K; Nozaki T; Katano H; Hasegawa H; Matsuo K; Hosokawa Y; Tando S; Fushiki S
Neuropathology; 2015 Feb; 35(1):64-9. PubMed ID: 25186798
[TBL] [Abstract][Full Text] [Related]
18. USE OF A HUMAN INDIRECT IMMUNOFLUORESCENCE ANTIBODY ASSAY FOR
Ferris RL; Ali IK; West G
J Zoo Wildl Med; 2021 Apr; 52(1):310-314. PubMed ID: 33827191
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
Baig AM
Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with Nitroxoline.
Spottiswoode N; Pet D; Kim A; Gruenberg K; Shah M; Ramachandran A; Laurie MT; Zia M; Fouassier C; Boutros CL; Lu R; Zhang Y; Servellita V; Bollen A; Chiu CY; Wilson MR; Valdivia L; DeRisi JL
Emerg Infect Dis; 2023 Jan; 29(1):197-201. PubMed ID: 36573629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
